 |
|
Free CME/CE Breakfast Workshop:
Overcoming Challenges in the Treatment of Relapsed/Refractory Multiple Myeloma
Seating is limited.
Reserve your seat today!
3 Convenient Ways to Register:
Visit www.Med-IQ.com/a706
Call (toll-free) 866 858 7434
E-mail info@med-iq.com
BECOME A MED-IQ MEMBER FOR FREE
Sign up today and access
award-winning medical education.
Learn more about your
member benefits.
Have questions?
Contact a Med-IQ Concierge Specialist. Call (toll-free)
866 858 7434 or e-mail
info@med-iq.com.
Med-IQ.
Inspiring Medical Education. |
 |
BALTIMORE, MD—June 25, 2013—Registration is now underway for a free CME/CE-certified breakfast workshop series designed to help hematology/oncology clinicians with the clinical management of relapsed/refractory multiple myeloma (RRMM).
Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education, is sponsoring this regional workshop series, Overcoming Challenges in the Treatment of Relapsed/Refractory Multiple Myeloma, in select cities across the country this summer:
Recent advances in the management of multiple myeloma have led to significant improvements in response rates and overall survival. Healthcare providers are often faced with challenges when treating these patients, including selecting optimal treatment strategies for patients with relapsed or refractory disease. Although several agents are effective in the salvage setting, when making therapeutic decisions, it is important to consider clinical evidence, patient-related factors, treatment-related side effects, quality of life, and the role of autologous stem cell transplant.
Using both didactic and case-based learning, along with small-group peer discussions and Q&A with nationally renowned faculty experts, participants will explore the latest clinical evidence and guideline recommendations for the optimal management of patients with RRMM. A unique component of the workshop series is the inclusion of patient videos, where participants will hear first hand from patients about real-world challenges of living with this disease.
The workshops will be held from 7:30 to 10:30 AM; breakfast will be served. Space is limited. Hematologists, oncologists, nurses, and members of their clinical care teams can register for free by calling (toll-free) 866 858 7434, e-mailing info@med-iq.com, or completing this brief online form. For more information on workshop locations and agenda, please visit www.Med-IQ.com/a706.
FACULTY
 |
|
Sagar Lonial, MD
Professor and Vice Chair of Clinical Affairs
Department of Hematology and Medical Oncology
Director of Translational Research, B-Cell Malignancy Program
Winship Cancer Institute
Emory University School of Medicine
Atlanta, GA
|
| |
|
|
 |
|
Rafael Fonseca, MD
Getz Family Professor of Cancer
Chair, Department of Medicine
Mayo Clinic
Scottsdale, AZ
|
| |
|
|
 |
|
Keith Stewart, MB, ChB
Dean for Research
Mayo Clinic
Scottsdale, AZ
|
This activity is approved for AMA PRA Category 1 Credit™.
Med-IQ is accredited by the California Board of Registered Nursing to provide continuing education to nurses.
This activity is supported by educational grants from Celgene Corporation, Millennium: The Takeda Oncology Company, Novartis Pharmaceuticals Corporation, and Onyx Pharmaceuticals.
|
About Med-IQ
Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
Med-IQ, a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives, has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact: |
close
